Journal details
SIGNAL TRANSDUCTION AND TARGETED THERAPY
SPRINGERNATURE · ISSN 2095-9907 · eISSN 2059-3635
SCIEScopusMEDLINEPubMedPMCDOAJ
Overview
SIGNAL TRANSDUCTION AND TARGETED THERAPY. ISSN 2095-9907 · eISSN 2059-3635. published by SPRINGERNATURE. Peoples R China. Biochemistry & Molecular Biology · Cell Biology. impact factor 81.2 (2025). JCR Q1. CAS Zone 1 TOP. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 239 articles · 2025: 429 articles · 2024: 371 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of SIGNAL TRANSDUCTION AND TARGETED THERAPY?
The impact factor recorded for SIGNAL TRANSDUCTION AND TARGETED THERAPY is 81.2 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of SIGNAL TRANSDUCTION AND TARGETED THERAPY?
SIGNAL TRANSDUCTION AND TARGETED THERAPY is listed in CAS Zone 1 and marked as a TOP journal.
Which databases index SIGNAL TRANSDUCTION AND TARGETED THERAPY?
SIGNAL TRANSDUCTION AND TARGETED THERAPY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC, DOAJ. Confirm on the journal website and the database itself before submitting.